Mapletree Pan Asia Commercial Trust (MPACT) - DBS Research 2022-09-14: Opportunity Not To Be Missed

• We believe this is an opportune time to ride on the potential upside of Mapletree Pan Asia Commercial Trust (MPACT, SGX:N2IU)’s portfolio optimization and recovery post the merger when valuation is still attractive.

Strong recovery post reopening in MPACT's key markets (Singapore, Hong Kong, China).

Singapore recovery has surpassed pre-COVID and expect more to come as tourism returns to normal.

• - Read this at SGinvestors.io -
• According to our observations and on-the-ground research, we understand that most retailers believe the strong tenant sales that we have seen recently, could be sustainable. With the recovery of tenant sales, VivoCity’s NPI in 1Q23 has also surpassed that of pre-COVID levels at ~110%.
• - Read this at SGinvestors.io -

Hong Kong recovery next in line.

• Read more at SGinvestors.io.

Above is an excerpt from a report by DBS Group Research.
Clients of DBS may access the full PDF report @ https://www.dbs.com/insightsdirect/.

Read also DBS's most recent report:
2025-04-29 Mapletree Pan Asia Commercial Trust - Gradual Rebuild From A Solid Core.

Previous report by DBS:
2025-01-23 Mapletree Pan Asia Commercial Trust - Potential De-risking Of Mapletree Business City Anchor Lease.

Price targets by 3 other brokers at Mapletree Pan Asia Commercial Trust Target Prices.

Listing of research reports at Mapletree Pan Asia Commercial Trust Analyst Reports.

Relevant links:
Mapletree Pan Asia Commercial Trust Share Price History,
Mapletree Pan Asia Commercial Trust Announcements,
Mapletree Pan Asia Commercial Trust Dividend Payout Dates & Corporate Actions,
Mapletree Pan Asia Commercial Trust News